Novotech Joins Expert Panel at AACR for eChinaHealth Session on Collaborating with China’s Cancer Research Sector
The latest data shows Asia Pacific is also the fastest-growing region globally for cell & gene therapy trials representing more than a third of all cell & gene studies, with China leading in the region.
- The latest data shows Asia Pacific is also the fastest-growing region globally for cell & gene therapy trials representing more than a third of all cell & gene studies, with China leading in the region.
- Oncology accounts for the majority of cell & gene therapy trials.
- In addition, the Asia Pacific is the leading location globally for CAR-T trials with China attracting ~60% of all CAR-T trials globally between 2015-2022.
- Novotech has recently acquired EastHORN a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent.